The global eye care supplement market is anticipated to reach a valuation of US$ 2,457.5 million in 2024, driven by consumer convenience. The trend is expected to create new opportunities for the market, leading to a projected CAGR of 6.5% between 2024 and 2034, and reaching a total valuation of approximately US$ 4,613.0 million by 2034.

One of the major factors contributing to the growth of the market is the advancements in supplement delivery systems, such as nanoemulsions or encapsulation technologies, can enhance the bioavailability of key nutrients, improving the effectiveness of eye care supplements.

Request a Sample copy of this Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-18472

Consumers are increasingly looking for preventive health measures rather than just treatment options. Eye care supplements positioned as preventive measures against age related eye conditions are expected to see heightened demand.

Ongoing research into novel ingredients with potential benefits for eye health can lead to the development of innovative supplements. Ingredients such as lutein, zeaxanthin, omega 3 fatty acids, and astaxanthin continue to be areas of interest.

The incorporation of eye health promoting ingredients into functional foods and beverages, in addition to traditional supplement forms, is gaining popularity. Educational initiatives about the importance of eye health and the role of supplements through advertising, social media, and other channels can influence consumer behavior and drive market growth.

There is a growing potential for the eye care supplement market to expand in regions where eye health may not have been a primary focus previously, as healthcare awareness increases in emerging markets.

Key Takeaways from the Market Study:

• Global eye care supplement market was valued at US$ 2,301.8 million by 2023-end.
• From 2019 to 2023, the market demand expanded at a CAGR of 6.0%.

• The market in the United States is expected to expand at a CAGR of 7.0% through 2034.

• By dosage form, the tablet segment to account for a share of 21.5% in 2024.

• From 2024 to 2034, eye care supplement market is expected to flourish at a CAGR of 6.5%.
• By 2034, the market value of eye care supplement is expected to reach US$ 4,613.0 million.

Technology integration, such as mobile apps for tracking eye health and supplement adherence, can create new avenues for consumer engagement and product differentiation, opines Sabyasachi Ghosh Associate Vice President at Future Market Insights (FMI).Top of Form

Recent Developments:

• In 2023, Bausch + Lomb Corporation announced the release of PreserVision® AREDS 2 Formula soft gels with added coenzyme Q10. Designed as a convenient two in one solution, PreserVision AREDS 2 Formula eye vitamins, combined with CoQ10, stand as the sole eye vitamin integrating the precise nutrient formula endorsed by the National Eye Institute. The combination aims to reduce the risk of moderate to advanced progression of Age related Macular Degeneration while also supporting heart health.
• In 2022, Wellbeing Nutrition, a prominent research based wholefood nutrition company in India, unveiled Melts Eye Care, which is an all natural eye vitamin.

Key Companies Profiled:

• Novartis AG
• Bausch & Lomb Incorporated
• Amway Corp.
• Vitabiotics Ltd.
• Alliance Pharma
• The Nature's Bounty Co
• ZeaVision, LLC.
• Akorn Consumer Health
• Eyescience Labs
• Kemin Industries Inc.
• NutraChamps
• Nutrivein
• Biosyntrx Inc
• Nordic Naturals Inc.
• Bristol-Myers Squibb Company
• Healths Harmony LLC
• NUSAPURE
• Vitabiotics Ltd.
• EyeScience
• Butterflies Healthcare Ltd.
• Allergan plc
• Herbalife Nutrition Ltd.

Segmentation Analysis of the Eye Care Supplement Market:

By Ingredients:

• Lutein and Zeaxanthin
• Antioxidants
• Omega 3 Fatty Acids
• Coenzyme Q10
• Flavonoids
• Astaxanthin
• Alpha Lipoic Acid
• Others

By Dosage Form:

• Tablet
• Capsules
• Gels
• Liquid
• Gummies

By Route of Administration:

• Oral
• Topical
• Parental

By Indication:

• Age Related Macular Degeneration
• Cataract
• Dry Eye Syndrome
• Glaucoma
• Others

By Distribution Channel:

• Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies
• Ophthalmic Stores

By Region:

• North America
• Latin America
• Western Europe
• Eastern Europe
• South Asia & Pacific
• East Asia
• The Middle East & Africa